Research Overview: Sermorelin
Sermorelin is a synthetic peptide consisting of the first 29 amino acids of naturally occurring growth hormone releasing hormone (GHRH). This bioactive sequence represents the minimal fragment required for full biological activity at GHRH receptors in laboratory models. Researchers at Stroid UK Shop investigate this compound’s mechanism of action through selective binding to pituitary GHRH receptors, which subsequently modulates adenylyl cyclase activity and cAMP signalling pathways in cellular research systems.
Laboratory Applications
Scientists utilise Sermorelin in neuroendocrine research to examine growth hormone axis regulation and pituitary function. The compound serves as a valuable research tool for studying hypothalamic-pituitary interactions in controlled laboratory environments. Research applications include investigating circadian rhythm effects on growth hormone secretion, examining age-related changes in GHRH sensitivity, and evaluating receptor binding kinetics through competitive binding assays. Advanced peptide research protocols often incorporate Sermorelin alongside other growth hormone secretagogues for comparative analysis studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Growth Hormone Releasing Hormone (1-29) |
| CAS Number | 86168-78-7 |
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S |
| Molecular Weight | 3357.88 g/mol |
| Purity | ≥98% (HPLC verified) |
| Physical Form | Lyophilised white powder |
| Storage Temperature | -20°C (long-term), 2-8°C (short-term) |
| Solubility | Water, bacteriostatic water |
Researchers studying growth hormone biology often combine Sermorelin investigations with broader SARM research programmes to understand anabolic signalling cascades. The compound’s stability profile requires careful handling protocols, with reconstituted solutions maintaining potency for up to 30 days when stored at appropriate temperatures. Laboratory teams frequently utilise this peptide in conjunction with comprehensive peptide research portfolios for multi-pathway analysis studies.
Research Compliance
This product is intended exclusively for in-vitro laboratory research purposes. Sermorelin 2mg Beligas is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and local regulations governing peptide research compounds before conducting any experimental protocols.
